52 articles matched your search
- Practice Area:Pharma/BiotechRemove this filter
Sort By: Newest first | Oldest first
Court of Appeal confirms cross-border non-infringement jurisdictiondownload
The Court of Appeal has confirmed that the English court has cross-border non-infringement jurisdiction.
Cambridge Technology and Life Sciences Update — May 2013weblink
Taylor Wessing has released the May 2013 edition of its Cambridge Technology and Life Sciences Update.
Data Protection Policies — update from Global Data Hubweblink
Taylor Wessing has added a fresh batch of data-protection-focused content to its Global Data Hub site.
Health Alert — 6 May 2013download
The 6 May 2013 issue of DLA Piper’s Health Alert publication is available now.
Health Alert — 13 May 2013download
The 13 May 2013 issue of DLA Piper’s Health Alert publication is available now.
Healthcare advertising in the UAEdownload
Many changes are afoot in respect of healthcare and pharmaceuticals in the UAE. There is a real push to improve standards relating to health and medicine across the board.
DLA Piper advises Healthcare Buying Group on its acquisition of DBG
DLA Piper has advised Healthcare Buying Group on its acquisition of DBG (UK) from Synova Capital.
Patients First and Foremost, the government’s initial response to the Francis Reportweblink
Patients First and Foremost, the government’s initial response to the Francis Report, was published just before Easter.
STARK 101: essential questions for every Stark analysisdownload
This article offers some simple tools to help guide compliance officers, executives, new lawyers and others in evaluating whether Stark may prohibit a proposed or existing arrangement.
Procurement Update — Spring 2013weblink
The spring 2013 issue of Walker Morris’s Procurement Update covers topics such as the EU procurement reforms, the Utilities Directive and NHS healthcare services.
The Law Sciences Law Review — first editiondownload
The Life Sciences Law Review explores legal issues of special interest to pharmaceutical, biotechnology and medical device companies in 27 jurisdictions.
Implications of OIG’s fraud alert on current PODs and their customers and suppliersweblink
OIG’s ‘Special Fraud Alert on Physician-Owned Entities’ is the strongest statement to date that investing in or doing business with a POD is a significant Antikickback law risk.
Government consults on compulsory data protection audits for NHSdownload
The government has launched a consultation on whether NHS organisations should be made subject to compulsory data protection audits.
Ashurst joins US and Irish firms as Elan rejects Royalty Pharma bid
A raft of Irish, UK and US firms have won roles on the battle for control of Irish biotechnology company Elan, which yesterday rejected an offer from Royalty Pharma.
A second stem cell patentability case is referred to the CJEUdownload
Henry Carr QC, sitting as a deputy High Court judge in the Patents Court, has made only the second reference to the CJEU for a preliminary ruling on the patentability of stem cells.
Responsible commissioner: making sense of the new rules and guidancedownload
This briefing is intended to cut through the pages of small print and to see where CCGs will stand in the new world order when it comes to planning and securing services for patients.
When re-litigating a patent may be permitteddownload
In Resolution v Lundbeck, Arnold J has allowed Resolution Chemicals Ltd to pursue its own revocation proceedings against Lundbeck’s SPC/GB02/049 protecting escitalopram.
Synapse — Law for Life Sciences — April 2013weblink
Taylor Wessing has released the April 2013 edition of Synapse, its publication dedicated to law for life sciences.
Chambers and Partners 2013 ranks Hogan Lovells' life-sciences practice in band one
Hogan Lovells’ global life-sciences practice has been placed in band one for the second year running in the Chambers and Partners Global 2013 rankings.
Mourant Ozannes advises group of investors on sale and leaseback of 12 private hospitals
Mourant Ozannes has advised a consortium of investors on the £700m sale and leaseback of 12 UK private hospitals from the Spire Healthcare Group.
View results 10 per page | 20 per page | 50 per page
